Article
Immunomodulation does not alter histology in resected Crohn's disease.
Techniques in coloproctology - 1 Dec 2009
Frizelle F A, Ing A, Gearry R B, Whitehead M, Faragher I G, Dobbs B
Abstract excerpt
BACKGROUND: The use of immunomodulators (Azathioprine, 6-Mercaptopurine and Methotrexate) and biological agents (Infliximab and adalimumab) for the treatment of Crohn's disease (CD) has increased in the recent years with the aim of treating the inflammatory component of the disease and hoping to change the natural history of the disease. The aim of this study was to determine if the use of immunomodulators or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.